Vokanamet is a prescription medication used in the management of type 2 diabetes, a condition characterized by high blood sugar levels due to the body's inability to produce enough insulin or use insulin effectively. It is a combination drug that contains two active ingredients: canagliflozin and metformin. Canagliflozin belongs to a class of drugs known as sodium-glucose co-transporter 2 (SGLT2) inhibitors, which work by helping the kidneys remove glucose from the bloodstream through the urine. Metformin, on the other hand, decreases glucose production in the liver and improves the body's sensitivity to insulin. Together, these medications help to control blood sugar levels, thereby reducing the risk of diabetes-related complications. Vokanamet is typically prescribed when diet and exercise alone have not been enough to control blood sugar levels, and it may be used in combination with other diabetes medications as part of a comprehensive treatment plan.